Restoring vision lost to retinal degeneration

Article

Results from research performed by St Jude Children's Research Hospital has demonstrated vision lost as a result of glaucoma, diabetic retinopathy and age-related macular degeneration (AMD) may be restored.

Results from research performed by St Jude Children's Research Hospital has demonstrated vision lost as a result of glaucoma, diabetic retinopathy and age-related macular degeneration (AMD) may be restored.

The research has supported evidence that the Six3 gene plays a pivotal role in developing the nervous system as a key regulator of the Wnt family of signalling proteins, which can disrupt the process of retinal formation. This is an expansion of previous work by Dr Guillermo Oliver who is the senior author of the research being published in the Journal of Clinical Investigation.

"A few years ago we determined that very early in development Six3 is required for repressing one member of the Wnt family, a gene called Wnt1, to allow proper development of the forebrain. With this new research we show that a few hours later Six3 is called on again, this time to repress a different Wnt family member, Wnt8b, so formation of the retina can begin," reported Dr Oliver.

Unlike some animals it is not possible for humans to regenerate retinal cells lost to age or illnesses. Therefore, understanding of the genes and molecular mechanisms involved in normal retinal development is key to developing stem-cell or other cell-based replacement therapies to correct vision or treat blindness.

Dr Oliver continued: "Our findings provide a molecular framework to the developmental programme leading to retina differentiation. The work may also be relevant for devising novel strategies aimed at characterizing and eventually treating different abnormalities in eye formation."

For more detailed information on this research visit the website at www.stjude.org

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.